9
Clinical Trials associated with mRNA Vaccine (VP7 TIAV-VPT Protein) / Not yet recruitingNot ApplicableIIT A clinical trial on booster immunization of two kinds of COVID-19 vaccines among people aged 18 years and older
To evaluate the safety and preliminary immunogenicity of COVID-19 mRNA vaccine in healthy population aged 18 years and older: a randomized, blinded, parallel controlled phase I clinical trial
Start Date23 Mar 2023 |
Sponsor / Collaborator- |
/ Not yet recruitingNot ApplicableIIT Intraspecific randomized, blinded, parallel-controlled sequential booster study of a novel coronavirus mRNA vaccine in a population aged 18 years and older who have completed 3 doses of inactivated neo-coronavirus vaccine
100 Clinical Results associated with mRNA Vaccine (VP7 TIAV-VPT Protein)
100 Translational Medicine associated with mRNA Vaccine (VP7 TIAV-VPT Protein)
100 Patents (Medical) associated with mRNA Vaccine (VP7 TIAV-VPT Protein)
100 Deals associated with mRNA Vaccine (VP7 TIAV-VPT Protein)